Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
LOTTE Fine Chemical Co., Ltd. (004000.KS)
Ulsan, KR
Operating from its headquarters in Ulsan, South Korea, LOTTE Fine Chemical Co., Ltd. produces and distributes a wide array of chemical products domestically. Its extensive portfolio includes various cellulose derivatives, such as MECELLOSE, hydroxyethyl cellulose, AnyCoat-C (hypromellose), and AnyCoat-P (hypromellose phthalate), which are utilized across diverse industries like construction, cement and ceramic manufacturing, coatings, pharmaceuticals, and consumer goods. The company also supplies essential industrial chemicals, including epichlorohydrin, caustic soda, methyl and methylene chloride, chloroform, sodium hypochlorite, methaclean, hydrochloric acid, and PTAC, vital for the architectural, textile, and resin sectors. Furthermore, its product lines extend to general chemicals like EUROX, ammonia, ammonium hydroxide, monomethylamine, dimethylamine, trimethylamine, and trimethylamine-HCl. They are also a key supplier of tetramethyl ammonium hydroxide, a crucial material for semiconductor manufacturing, and specialized polymerized toners designed for color laser printers. The company, established in 1964, was formerly known as SAMSUNG Fine Chemicals Co., Ltd. before it rebranded to LOTTE Fine Chemical Co., Ltd. in 2016.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.19% | -4.87% | -25.98% | +3.13% | +15.44% | +22.70% | +40.16% | -11.43% | -20.51% | +49.08% | +168.19% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 4 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+4.9% ★ Q1'26: +14.6% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+191.7% ★ Q1'26: +55.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+3.7% Q1'26: +7.8% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+4.2% Q1'26: +6.4% (vs Q1'25)
-
ROIC Chemicals: +3.4%+3.2% Q1'26: +5.1% (vs Q1'25)
-
Share dilution Chemicals: +0.0%0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.28× ★ Q1'26: 0.22× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 4 EPS Ana. |
Dec 2027 6 Rev. Ana. 6 EPS Ana. |
Dec 2028 2 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.16T
est: 1.18T (-1.5%)
|
1.11T
est: 1.16T (-4.4%)
|
1.16T
est: 1.20T (-3.7%)
|
1.37T
est: 1.37T (0.0%)
|
1.31T
est: 1.31T (+0.2%)
|
1.26T
est: 1.26T (+0.1%)
|
1.78T
est: 1.80T (-0.9%)
|
2.46T
est: 2.56T (-3.7%)
|
1.77T
est: 1.76T (+0.4%)
|
1.67T
est: 1.68T (-0.8%)
|
1.75T
est: 1.76T (-0.4%)
|
1.94T
1.85T – 2.03T
+10.2% YoY
|
1.98T
1.78T – 2.17T
+2.1% YoY
|
2.06T
1.90T – 2.20T
+3.8% YoY
|
| EBITDA |
75.34B
est: 220.12B (-65.8%)
|
26.31B
est: 216.82B (-87.9%)
|
182.79B
est: 224.83B (-18.7%)
|
281.82B
est: 256.03B (+10.1%)
|
287.74B
est: 244.25B (+17.8%)
|
334.48B
est: 235.57B (+42.0%)
|
635.51B
est: 335.17B (+89.6%)
|
74.83B
est: 477.49B (-84.3%)
|
293.34B
est: 328.74B (-10.8%)
|
192.54B
est: 270.98B (-28.9%)
|
238.64B
est: 283.18B (-15.7%)
|
312.12B
298.39B – 326.63B
+10.2% YoY
|
318.57B
285.65B – 348.45B
+2.1% YoY
|
330.72B
306.28B – 353.98B
+3.8% YoY
|
| EBIT |
126.08B
est: 131.61B (-4.2%)
|
-55.23B
est: 129.64B (-142.6%)
|
120.69B
est: 134.43B (-10.2%)
|
200.92B
est: 153.08B (+31.2%)
|
195.59B
est: 146.04B (+33.9%)
|
228.51B
est: 140.85B (+62.2%)
|
515.27B
est: 200.40B (+157.1%)
|
-48.71B
est: 285.50B (-117.1%)
|
154.78B
est: 196.56B (-21.3%)
|
33.19B
est: 141.30B (-76.5%)
|
74.37B
est: 147.65B (-49.6%)
|
162.75B
155.59B – 170.31B
+10.2% YoY
|
166.11B
148.94B – 181.69B
+2.1% YoY
|
172.45B
159.70B – 184.58B
+3.8% YoY
|
| Net Income |
93.87B
est: 100.96B (-7.0%)
|
-43.55B
est: -36.29B (-20.0%)
|
89.23B
est: 104.83B (-14.9%)
|
214.92B
est: 212.10B (+1.3%)
|
168.37B
est: 168.75B (-0.2%)
|
198.79B
est: 165.85B (+19.9%)
|
585.46B
est: 484.10B (+20.9%)
|
146.16B
est: 247.28B (-40.9%)
|
182.03B
est: 214.30B (-15.1%)
|
36.38B
est: 48.83B (-25.5%)
|
106.09B
est: 116.87B (-9.2%)
|
174.78B
147.84B – 226.85B
+49.6% YoY
|
168.44B
127.42B – 211.42B
-3.6% YoY
|
177.31B
160.27B – 193.52B
+5.3% YoY
|
| SGA |
59.47B
est: 45.70B (+30.1%)
|
53.12B
est: 45.02B (+18.0%)
|
56.16B
est: 46.68B (+20.3%)
|
42.96B
est: 53.16B (-19.2%)
|
48.27B
est: 50.71B (-4.8%)
|
48.20B
est: 48.91B (-1.4%)
|
55.06B
est: 69.59B (-20.9%)
|
68.50B
est: 99.14B (-30.9%)
|
100.53B
est: 68.25B (+47.3%)
|
66.85B
est: 64.88B (+3.0%)
|
64.93B
est: 67.80B (-4.2%)
|
74.73B
71.44B – 78.20B
+10.2% YoY
|
76.27B
68.39B – 83.42B
+2.1% YoY
|
79.18B
73.33B – 84.75B
+3.8% YoY
|
| EPS |
3,685.00
est: 3,964.00 (-7.0%)
|
-1,710.00
est: -1,425.00 (-20.0%)
|
3,503.00
est: 4,115.75 (-14.9%)
|
8,438.29
est: 8,327.50 (+1.3%)
|
6,610.59
est: 6,625.50 (-0.2%)
|
7,804.94
est: 6,511.50 (+19.9%)
|
22,986.00
est: 19,006.75 (+20.9%)
|
5,738.48
est: 9,708.75 (-40.9%)
|
7,146.90
est: 8,414.00 (-15.1%)
|
1,428.00
est: 1,917.60 (-25.5%)
|
4,165.41
est: 4,589.67 (-9.2%)
|
6,864.00
5,805.87 – 8,908.65
+49.6% YoY
|
6,615.00
5,004.10 – 8,302.76
-3.6% YoY
|
6,963.00
6,293.98 – 7,599.62
+5.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-28 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-27 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-26 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-22 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-21 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-20 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-19 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex Energy&Chemicals 117460.KS | 0.99% | 167.7K | 0.45% |
| 2 | Kodex 200 Mid-Small 226980.KS | 0.51% | 69.9K | 0.30% |
| 3 | First Trust Developed Markets ex-US Small Cap AlphaDEX Fund FDTS | 0.30% | 39.1K | 0.80% |
| 4 | Kodex MSCI Value 275290.KS | 0.20% | 46.5K | 0.30% |
| 5 | Kodex Dividend Value 325020.KS | 0.11% | 90.3K | 0.30% |
| 6 | Kodex 200 Intrinsic Value 223190.KS | 0.07% | 13.5K | 0.30% |
| 7 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.05% | 54.8K | 0.42% |
| 8 | FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE | 0.05% | 158.2K | 0.58% |
| 9 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.04% | 28.2K | 0.74% |
| 10 | Schwab Fundamental International Small Company Index ETF FNDC | 0.03% | 1.02M | 0.39% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Seong-won Chung | Chief Executive Officer & Chairman | 2B | male |
| Gi-sun Kim | Internal Accounting Manager & Inside Director | — | male |
| Heeyong Yoon | Inside Director | — | male |
| Jae-Woong Jung | Deputy MD & Director of Technology Department | — | male |
| Woo-Hyun Cho | Deputy MD & Director of Business Management Department | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 004000.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
